Celldex Therapeutics reported that its medicine for a condition that causes chronic hives reduced hive activity and, notably, ...

Chronic urticaria occurs in about 0.1% of the population (Greaves, 2000). Patients previously classified as having chronic idiopathic or "ordinary" urticaria are now divided into two groups: 40% ...

The incidence of mental disorders such as anxiety, depression, and sleep disturbance was higher among patients with chronic urticaria (CU) than in patients with acute urticaria (AU). Medication ...

However, hives aren’t contagious—they cannot be spread from one person to another. Other rash types, such as those due to chronic autoimmune skin conditions like eczema or psoriasis ...

In a case reported by Baptist and Baldwin (2004), a 33-year-old woman with a history of endometriosis presented with complaints of chronic urticaria ... was diagnosed with autoimmune progesterone ...

Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with chronic spontaneous urticaria, an inflammatory skin disease, in a late-stage trial, the companies announced on ...

Chronic urticaria last longer than six weeks and ... contact with water, certain autoimmune conditions, and tight clothes or straps that irritate the skin. When you do get hives, there are some ...

CSU is a chronic skin condition that causes sudden and debilitating hives and persistent itch, which can impact quality of life. This positive trial confirms results from Study A, the first Phase ...

but can now point to a win for rilzabrutinib in chronic spontaneous urticaria (CSU). In a phase 2 trial, rilzabrutinib has been shown to rapidly reduce itch severity and significantly improve ...

(150 mg Q4W) achieved complete response at Week 52 -- Rapid, profound and durable improvement in UAS7 as early as Week 1 with a ...